Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00595166 · ClinicalTrials.gov registry record

Using a Sheathed Speculum to Visualize and Access the Cervix in Women With Excessive Vaginal Tissue

A clinical trial, sponsored by University of South Florida.

Terminated
Registry status
38
Enrollment target

NCT00595166: Clinical Trial study, sponsored by University of South Florida.

NCT00595166 is a clinical trial that was terminated before completion, run by University of South Florida. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00595166 was terminated before completion, sponsored by University of South Florida.

TERMINATED
Registry status
38 participants
Enrollment target

Study Summary

This new invention addresses the inadequate and incomplete visualization of the cervix in patients with excessive vaginal tissue. In general these patients are obese, or are multiparous with a history of multiple vaginal deliveries. A vaginal speculum is a vital medical instrument that allows a health care provider to visualize the interior aspects of the vagina, as well as the distal portion of the uterus, the cervix. It is composed of 2 blades assembled together and held by a handle. The blades and the handle form a 90 degree-angle. As the user holds the handle, a lever attached to the top blade allows it to open away from the inferior blade. When the instrument is inserted into the vagina, the two blades are separated in order to keep the anterior and posterior vaginal walls apart. In that position, the cervix and the walls of the vagina can be seen if the patient does not have an excess of loose vaginal tissue. However, in patients with excessive tissue, the sidewalls of the vagina simply collapse toward the midline between the blades because of the fact that no part of the speculum is in direct contact with the lateral walls of the vagina. This collapse prevents the complete and crucial visualization of the cervix for purposes of cervical cultures, pap smears, visual assessment of ruptured membranes, visual assessment of the degree of dilation, biopsies, and other procedures requiring access to the cervix or the uterus. When clinicians face this dilemma, they may try the largest speculum available, and will open it as wide as possible in order to keep the lateral walls apart. Most often, they have to improvise by cutting the tip of a condom, or the thumb off a glove, or they use a sterile lateral-wall retractor. These other creative solutions can take several minutes of precious times and may still result in an inadequate visualization and suboptimal access. A vaginal speculum sheath for retaining vaginal tissue in a lateral direction conforms to a pair of

Interventions

  • DEVICE Vaginal Speculum Sheath

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2007-06
Est. Completion 2013-03
University of South Florida

252 total trials

Why NCT00595166 stopped before completion

NCT00595166 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Vaginal Speculum Sheath is the first listed.

NCT00595166 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00595166 about?

NCT00595166 is a clinical study titled "Using a Sheathed Speculum to Visualize and Access the Cervix in Women With Excessive Vaginal Tissue". This new invention addresses the inadequate and incomplete visualization of the cervix in patients with excessive vaginal tissue. In general these patients are obese, or are multiparous with a history of multiple vaginal deliveries. A vaginal speculum is a vital medical instrument that allows a hea...

What is the current status of trial NCT00595166?

This trial is currently terminated. The enrollment target is 38 participants. The study started on 2007-06. Estimated completion is 2013-03.

What interventions are being tested in trial NCT00595166?

The interventions under investigation include: Vaginal Speculum Sheath (DEVICE).

Who is sponsoring clinical trial NCT00595166?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00595166, the US trial registry maintained by the National Library of Medicine. NCT00595166 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.